Nonetheless, following tests for non-inferiority superiority was assessed and semaglutide 14 mg demonstrated a greater reduction in A1C (%) when compared to empagliflozin (PIONEER 2), as did semaglutide 7 mg and 14 mg when compared to sitagliptin (PIONEER 3)
Journal of Clinical Pharmacology, 40(12), 1399-1418
For compounded semaglutide patients, 2.4 mg sits at the top end of most titration schedules
Other meta-analyses of berberine for hyperlipidemia, hypertension, or diabetes also determined that most studies are of limited quality (2) (37)
Supplementary data Supplementary material to this article can be found online at References Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational crosssectional study
doi:10.1111/j.1460-9568.2009.06770.x Ayman J, Palotai M, Dochnal R, Bagosi Z